By J.D. Mowery, President, Bora CDMO Business
Scaling a business is never simple. Growth brings opportunity, but it also brings complexity, especially when that growth spans different countries, cultures, and ways of working. As organizations expand across geopolitical boundaries, one of the greatest challenges is ensuring that teams remain aligned, connected, and moving forward with a shared purpose.
At Bora Pharmaceuticals, we have experienced rapid growth in recent years, expanding to nine sites across Taiwan, the United States, and Canada (including our Bora Biologics business). With this growth comes an important question: how do we foster strength and success across the entire organization while building a unified culture that supports our people, our customers, and patients? The answer is not found only in integrating systems or standardizing processes. True alignment requires a culture that everyone can believe in, contribute to, and take ownership of, regardless of location. It’s this culture that ensures our partners can trust any Bora site to deliver the same quality and operational excellence across every project and product.
Uniting the Organization with Shared Values
When companies scale quickly, it is easy for silos to form. Different sites may develop different norms, expectations, and approaches to execution. Over time, those differences can create inconsistency and inefficiency, which is the opposite of what customers need from a global CDMO partner. That is why we’ve focused on creating a shared way of working across our organization: The Bora Way.
The Bora Way is our commitment to building one culture across all sites, grounded in shared values and shared responsibility. It is designed to ensure that whether a customer is working with a team in Taiwan, the U.S., or Canada, they experience the same level of quality, accountability, and partnership.
This culture is guided by our S.T.A.R. values:
Solutions-first approach – First and foremost, we focus on finding solutions rather than blaming others or prioritizing personal pride, communicating openly as we work towards delivering better results together.
We focus on solving challenges rather than simply identifying them.
To do the right thing– We take pride in holding high standards, taking ownership for our actions and building long-term partnerships by doing what is right.
Always be proactive – We stay one step ahead, working with pace and flexibility, taking the initiative to continually plan and strategize how we can do things better.
Respect everyone – We build inclusive environments where everyone can feel welcome and be themselves, treating others the way we want to be treated, and recognizing others’ achievements along the way.
Shared Responsibility, Shared Success
Together, these values create a shared mindset across Bora. Every employee understands that they are part of something larger than their individual site or role. Success at Bora is not local – it’s collective. When we operate as a unified organization, everything we do for customers is backed by the full strength of Bora’s global team. When our clients succeed in bringing high-quality drug products to the people who need them, we succeed.
In the CDMO space, clients depend on their partners for more than manufacturing capacity. They rely on consistency, transparency, and execution they can trust. The Bora Way reinforces a shared sense of ownership and responsibility across the organization, ensuring that every team understands the importance of their contribution to customer success. When people are aligned around the same values and expectations, our customers and, ultimately, patients, benefit from smoother collaboration, faster decision-making, and more predictable delivery.In the CDMO space, clients depend on their partners for more than manufacturing capacity. They rely on consistency, transparency, and execution they can trust. The Bora Way reinforces a shared sense of ownership and responsibility across the organization, ensuring that every team understands the importance of their contribution to customer success. When people are aligned around the same values and expectations, our customers and, ultimately, patients, benefit from smoother collaboration, faster decision-making, and more predictable delivery.
Building on Strong Foundations
As we build a global culture, we also recognize the strength of Bora’s origins. Taiwan has a long-standing history of manufacturing excellence, built on discipline, precision, and a deep commitment to quality. Bora’s roots in Taiwan have shaped our operational foundation, and as we expand internationally, we are applying that same emphasis across the entire organization. For Bora, quality is a global standard.
By combining cultural alignment through the Bora Way with the manufacturing rigor that has defined our legacy, we are creating an organization capable of delivering consistent results that positively impact customers and patients worldwide. These results speak for themselves. Across all Bora sites, more than 95% of projects are completed on time and in full, and our lot release times are consistently less than 60 days.* These outcomes are not accidental. They’re the product of shared values, strong execution, and a unified commitment to excellence.
Most businesses experience growing pains as they scale. However, the challenge of scaling across geographies and cultures also presents an opportunity to build something cohesive, resilient, and truly global. At Bora Pharmaceuticals, we believe that by investing in culture, aligning around shared values, and applying manufacturing excellence across every site, we can turn complexity into strong partnerships our customers can depend on. The Bora Way is how we create one organization, one standard, and one shared commitment to our customers and the people they serve, across every team and every site.
To hear more on this topic, watch J.D.’s full interview on the Making it in Manufacturing podcast here
J.D. Mowery has served as the president of Bora’s CDMO business since 2024. He brings nearly 25 years of leadership experience in the CDMO and biopharmaceutical industries, with a strong track record of driving innovation, growth, and operational excellence.
*Data as of Q1, 2026